(Q44304377)

English

Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 December 2017

Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study (English)

1 reference

Europe PubMed Central

1 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

Armando A. Genazzani

4

1 reference

Europe PubMed Central

1 December 2017

6

1 reference

Europe PubMed Central

1 December 2017

object named as

Paola Alberti

9

0 references

object named as

Sara Lonardi

11

0 references

Guido Cavaletti

object named as

Guido Cavaletti

2

0 references

Andreas A Argyriou

1

object named as

Andreas A Argyriou

1 reference

Europe PubMed Central

1 December 2017

author name string

Anna Antonacopoulou

3

1 reference

Europe PubMed Central

1 December 2017

Chiara Briani

5

1 reference

Europe PubMed Central

1 December 2017

Salvatore Terrazzino

7

1 reference

Europe PubMed Central

1 December 2017

Roser Velasco

8

1 reference

Europe PubMed Central

1 December 2017

Marta Campagnolo

10

1 reference

Europe PubMed Central

1 December 2017

Diego Cortinovis

12

1 reference

Europe PubMed Central

1 December 2017

Marina Cazzaniga

13

1 reference

Europe PubMed Central

1 December 2017

Cristina Santos

14

1 reference

Europe PubMed Central

1 December 2017

Aikaterini Psaromyalou

15

1 reference

Europe PubMed Central

1 December 2017

Aikaterini Angelopoulou

16

1 reference

Europe PubMed Central

1 December 2017

Haralabos P Kalofonos

17

1 reference

Europe PubMed Central

1 December 2017

language of work or name

0 references

publication date

2 July 2013

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

119

1 reference

Europe PubMed Central

1 December 2017

19

1 reference

Europe PubMed Central

1 December 2017

3570-3577

1 reference

Europe PubMed Central

1 December 2017

Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

A review on oxaliplatin-induced peripheral nerve damage.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Chemotherapy-induced peripheral neurotoxicity (CIPN): an update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Integrin beta-3 L33P: a new insight into the pathogenesis of chronic oxaliplatin-induced peripheral neuropathy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Overview of the voltage-gated sodium channel family

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

International Union of Pharmacology. XXXIX. Compendium of voltage-gated ion channels: sodium channels.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Oxaliplatin-induced neurotoxicity and the development of neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Genome-wide association study of PR interval

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Pain perception is altered by a nucleotide polymorphism in SCN9A

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Novel insights into the pathomechanisms of skeletal muscle channelopathies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Sickle cell disease: genetics, cellular and molecular mechanisms, and therapies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

21 January 2018

A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28234

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.28234

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44304377&oldid=2109308768"